# Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck

> **NCT00139243** · PHASE1,PHASE2 · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 30 (—)

## Conditions studied

- Squamous Cell Carcinoma
- Carcinoma of Head and/or Neck

## Interventions

- **DRUG:** Taxotere
- **DRUG:** Cisplatin
- **DRUG:** 5-Fluorouracil
- **DRUG:** Leucovorin

## Key facts

- **NCT ID:** NCT00139243
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-10
- **Primary completion:** 2006-01
- **Final completion:** 2006-01
- **Target enrollment:** 30 (—)
- **Last updated:** 2008-06-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00139243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00139243, "Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00139243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*